HRAUX
Price
$82.90
Change
-$0.26 (-0.31%)
Updated
Sep 20 closing price
RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

HRAUX vs RPTIX

Header iconHRAUX vs RPTIX Comparison
Open Charts HRAUX vs RPTIXBanner chart's image
Carillon Eagle Mid Cap Growth R6
Price$82.90
Change-$0.26 (-0.31%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
HRAUX vs RPTIX Comparison Chart
Loading...
VS
HRAUX vs. RPTIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HRAUX is a Buy and RPTIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. HRAUX (6.22B). RPTIX pays higher dividends than HRAUX: RPTIX (0.18) vs HRAUX (0.00). HRAUX was incepted earlier than RPTIX: HRAUX (13 years) vs RPTIX (9 years). RPTIX is a more actively managed with annual turnover of: 21.70 vs. HRAUX (3.00). HRAUX has a lower initial minimum investment than RPTIX: HRAUX (0) vs RPTIX (500000). RPTIX annual gain was more profitable for investors over the last year : 14.81 vs. HRAUX (8.45). HRAUX return over 5 years is better than : 21.00 vs. RPTIX (15.09).
HRAUXRPTIXHRAUX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years9 years-
Gain YTD6.6249.12773%
Front LoadN/AN/A-
Min. Initial Investment0500000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.22B31.4B20%
Annual Yield % from dividends0.000.18-
Returns for 1 year8.4514.8157%
Returns for 3 years-23.30-13.57172%
Returns for 5 years21.0015.09139%
Returns for 10 years78.70N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp